We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+5.71%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$22.7B
AUM Growth
+$2.61B
Cap. Flow
+$1.88B
Cap. Flow %
8.3%
Top 10 Hldgs %
32.91%
Holding
930
New
47
Increased
619
Reduced
193
Closed
47

Sector Composition

Rank Sector Weight
1 Materials 56.29%
2 Energy 16.8%
3 Healthcare 6.46%
4 Technology 3.59%
5 Industrials 2.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMZN icon
101
Amazon
AMZN
$2.5T
$41.2M 0.18%
930,340
-28,240
-3% -$1.18M
BMY icon
102
Bristol-Myers Squibb
BMY
$127B
$41.1M 0.18%
756,455
+116,064
+18% +$6.37M
NVDA icon
103
NVIDIA
NVDA
$5.01T
$39M 0.17%
14,330,360
+5,056,720
+55% +$13.5M
GORO icon
104
Goldgroup Mining Inc.
GORO
$151M
$37.8M 0.17%
8,363,447
+1,448,745
+21% +$7.44M
DRD
105
DRDGold
DRD
$1.82B
$37.1M 0.16%
7,563,368
+1,855,278
+33% +$10.4M
POT
106
DELISTED
Potash Corp Of Saskatchewan
POT
$37.1M 0.16%
2,170,972
+77,608
+4% +$1.41M
VRTX icon
107
Vertex Pharmaceuticals
VRTX
$121B
$36.8M 0.16%
336,864
-3,722
-1% -$328K
TXN icon
108
Texas Instruments
TXN
$255B
$36.4M 0.16%
452,435
+140,688
+45% +$10.9M
AMAT icon
109
Applied Materials
AMAT
$426B
$36.2M 0.16%
929,463
+337,654
+57% +$12.1M
AVGO icon
110
Broadcom
AVGO
$1.82T
$35.6M 0.16%
1,626,480
+309,520
+24% +$6.37M
MU icon
111
Micron Technology
MU
$1.04T
$35.4M 0.16%
1,225,770
+284,489
+30% +$6.95M
JNJ icon
112
Johnson & Johnson
JNJ
$635B
$34.6M 0.15%
277,591
-1,687
-0.6% -$202K
ASML icon
113
ASML
ASML
$675B
$34.2M 0.15%
257,622
+71,808
+39% +$8.83M
ARCC icon
114
Ares Capital
ARCC
$13.5B
$33.3M 0.15%
1,914,487
+534,042
+39% +$9.23M
ESV
115
DELISTED
Ensco Rowan plc
ESV
$32.9M 0.15%
919,041
+83,780
+10% +$3.4M
LOW icon
116
Lowe's Companies
LOW
$116B
$32.3M 0.14%
393,424
+36,706
+10% +$2.81M
ILMN icon
117
Illumina
ILMN
$29.4B
$32.2M 0.14%
194,171
-21,807
-10% -$3.44M
REGN icon
118
Regeneron Pharmaceuticals
REGN
$68.8B
$31.6M 0.14%
81,423
+10,479
+15% +$3.88M
NXPI icon
119
NXP Semiconductors
NXPI
$68B
$31M 0.14%
299,516
+103,959
+53% +$10.5M
PFE icon
120
Pfizer
PFE
$140B
$30.7M 0.14%
947,203
-20,801
-2% -$656K
LRCX icon
121
Lam Research
LRCX
$382B
$30.7M 0.14%
2,394,880
+1,071,490
+81% +$12.6M
VEON icon
122
VEON
VEON
$3.53B
$30.5M 0.13%
299,502
-13,190
-4% -$1.35M
ADI icon
123
Analog Devices
ADI
$181B
$30.5M 0.13%
372,678
+108,888
+41% +$8.55M
INCY icon
124
Incyte
INCY
$23.5B
$30.5M 0.13%
228,324
-23,748
-9% -$3.02M
V icon
125
Visa
V
$677B
$29.8M 0.13%
335,478
+49,382
+17% +$4.25M

Similar funds

VanEck Associates's Q1 2017 Portfolio in Review

As of Q1 2017, VanEck Associates held 930 positions worth $22.7B, up 13% from $20.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

VanEck Associates deployed $1.88B of net new capital in Q1 2017, opening 47 new positions and adding to 619 existing holdings. Its largest new stake was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.

By sector, the portfolio is most concentrated in Materials at 56% of assets, up from 54% a quarter earlier, followed by Energy and Healthcare.

On the sell side, the largest reduction was SM Energy, an estimated $89.9M trimmed.

  • VanEck Associates's largest Q1 2017 buy was Gold Standard Ventures Corp.: 23,596,878 shares worth $51M.
  • VanEck Associates added most to B2Gold in Q1 2017, an estimated $127M increase.
  • VanEck Associates's biggest Q1 2017 reduction was SM Energy, cutting an estimated $89.9M.
  • VanEck Associates fully exited Invesco DB US Dollar Index Bullish Fund in Q1 2017, selling an estimated $20.2M.
  • VanEck Associates's ten largest holdings make up 33% of its $22.7B portfolio in Q1 2017.
  • VanEck Associates opened 47 new positions and closed 47 in Q1 2017.
  • VanEck Associates's portfolio value rose 13% quarter-over-quarter to $22.7B.

Based on VanEck Associates's 13F filing for Q1 2017, filed 11 May 2017.